Amcomri Group, the AIM-quoted industrials “buy-and-build” acquirer, was flagged as slipping even as it reported sharply higher pre-tax profit for 2025. Yet the stock has more than doubled since its December 2024 float, and the headline percentage reflects a past snapshot rather than a single confirmed session. This is analysis, not advice; past performance is not a reliable indicator of future results.
Introduction
Amcomri Group plc (AIM: AMCO) is a UK industrials "buy-and-build" acquirer — a company whose strategy is to buy established small and medium-sized businesses, improve how they run, and add smaller "bolt-on" acquisitions to compound growth over time. It floated on London's Alternative Investment Market (AIM) on 20 December 2024 at 55p a share, raising £12m gross, and operates two divisions, Embedded Engineering and B2B Manufacturing, serving industrial customers. A recent market snapshot flagged the shares as down 2.5% "despite triple-digit earnings growth", a nod to the group's sharply higher 2025 pre-tax profit.
The framing deserves unpicking. The 2.5% figure is an earlier screener reading rather than a single confirmed trading day, and the "triple-digit earnings growth" refers chiefly to statutory profit before tax, which more than doubled. Neither, on its own, tells the whole story of a stock that has more than doubled from its float price. This piece separates the headline percentage, the latest quoted price and the confirmed fundamentals — and is intended as analysis, not a recommendation to buy or sell.
Putting the share-price move in context
As at the close on 3 August 2026, Amcomri shares stood at about 135.5p, giving a market capitalisation — the total value of the company's shares — of roughly £97.5m. On widely quoted market data the stock was down around 3.9% on that session, having opened near 143p. Over the past year the shares have traded between roughly 91p and 165p, so they sit below their 12-month high but well above the 55p at which they joined AIM less than two years ago.
The 2.5% decline in the headline is best read as a historical screener snapshot, not the latest session's move, and the two should not be conflated. Importantly, a single day's fall in a lightly traded small-cap can reflect little more than a modest sell order meeting a thin order book. No single company-specific catalyst had been officially confirmed at the time of writing, and correlation between the results and any share weakness is not the same as causation.
The numbers behind the ‘triple-digit’ claim
Amcomri published final results for the year to 31 December 2025 on 14 April 2026, having pre-announced the headline figures in a trading update on 11 March. Revenue rose about 22% to £70.9m (2024: £58.1m). Adjusted EBITDA — earnings before interest, tax, depreciation and amortisation, stripped of one-off and non-cash items to show underlying trading profit — grew roughly 19% to £9.2m (2024: £7.7m). The company said trading had come in significantly ahead of market expectations.
The "triple-digit" tag rests on the statutory numbers. Statutory profit before tax — the figure reported under accounting standards, before any adjustments — jumped from £1.7m to £4.1m, an increase of around 140%. Basic earnings per share, the profit attributable to each share in issue, rose about 20% to 4.2p. The gap between those growth rates matters: adjusted figures smooth out acquisition and financing costs, whereas the statutory leap partly reflects a low prior-year base. No dividend was declared.
Growth that is bought as well as built
Because the model is expansion by acquisition, it is essential to separate organic growth — sales generated by businesses the group already owned — from acquired growth, which comes from newly purchased companies. During 2025 Amcomri completed the acquisitions of EMC Elite Engineering Services in April and Randor Technologies in August, both folded into its engineering operations. It has stayed acquisitive into 2026, announcing a further deal in late March and completing another in June.
This is the essence of "buy-and-build": use a listed platform to acquire private companies, often at modest valuations, improve them and consolidate. Done well it can compound earnings quickly; done poorly it flatters reported growth while underlying trading stagnates. Management pointed to a mix of continued demand, organic improvement and deal-making. Investors should watch how much of the 22% revenue rise is genuinely organic once a full year of acquired revenue is stripped out, as that is the truer test of the platform's health.
The balance sheet: rising debt to fund deals
Acquisitions have to be paid for, and Amcomri's net debt — total borrowings less cash held — rose to £11.2m at the year-end, from £6.1m a year earlier. That is not alarming against £9.2m of adjusted EBITDA, but it is a trend worth monitoring. A serial acquirer that leans on borrowings becomes more sensitive to interest costs and to the prices it pays for future targets. Should earnings from acquired businesses disappoint, higher leverage magnifies the impact felt by shareholders.
Risks small-cap investors should weigh
Amcomri carries the hallmarks of an AIM micro-cap. Liquidity — the ease of buying or selling shares without moving the price — is limited, and the bid-offer spread (the gap between the buying and selling price) can be wide, so quoted percentage moves may overstate the value actually changing hands. The free float, at around a quarter of the shares at admission, is modest, concentrating trading in relatively few hands.
The strategy itself carries acquisition-integration risk: the danger that bought businesses prove harder to absorb, or perform worse, than expected. Buy-and-build stories can unravel if management overpays, overstretches the balance sheet or loses operational focus. AIM's lighter regulatory regime and thinner analyst coverage add to the uncertainty. Past performance — including the shares' strong run since flotation — is not a reliable indicator of future results.
The bottom line
On the confirmed facts, Amcomri delivered a genuinely strong 2025: revenue up around a fifth, adjusted profits higher, and statutory pre-tax profit more than doubled, aided by acquisitions and, the company says, organic improvement. The headline's "triple-digit earnings growth" is fair for statutory profit before tax, provided readers understand its acquisitive and low-base drivers. The "2.5%" fall, by contrast, is a dated snapshot rather than the latest verdict on the shares.
For now the investment case hinges on execution: whether Amcomri can keep buying sensibly, integrating cleanly and converting acquired revenue into durable cash flow while keeping debt in check. None of the above is a recommendation, and anyone weighing the shares should do their own research or seek independent advice.






Please wait processing your request...